α-synuclein aggregates extracted from synucleinopathy patients have been known to have heterogenous structures interestingly concurrent with the heterogeneity of disease phenotype, even by stage of a so-called singularly defined disease such as PD. Here, SNCA is linked to Parkinson disease.